About BSV Group
BSV Group is a Healthcare company based in Mumbai (India) founded in 1971, and was acquired by Mankind Pharma in July 2024. Provider of drug research development services for pharmaceutical sector. BSV Group has raised $64.91 million across 3 funding rounds from investors including Kotak Mahindra Bank, Mankind Pharma and Orbimed. BSV Group has completed 2 acquisitions, including Firstline and Genomicks. Its chief executive, as recorded, is Sanjiv Navangul. Its Indian entity Bharat Serums And Vaccines Limited reported revenue of ₹1,455 Cr. BSV Group offers products and services including Trinbelimab, Anti-Rho(D), Urinary Trypsin Inhibitor, and Recombinant FSH. Its focus areas include Diversified Pharmaceuticals and Drugs.
Company details
BSV Group, established in 1971 and currently in Acquired stage, focuses on providing healthcare solutions, diversified pharmaceuticals, and drugs. Provider of drug research development services for pharmaceutical sector. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Mumbai, India
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website bsvgroup.com
- Social LinkedIn X Instagram YouTube
- Acquired by Advent International (Nov 2019)
- Legal Name Bharat Serums And Vaccines Limited
- Date of Incorporation 29 Apr, 1971
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹1,455 Cr
FY 2023 · +15% YoY
- Net Profit₹51.64 Cr
FY 2023
- EBITDA₹121 Cr
FY 2023 · 8% margin
- Total Equity Funding$64.91M (USD)
in 3 rounds
- Latest Funding Round$46.76M (USD), Series C
Dec 2021
- InvestorsKotak Mahindra Bank
& 3 more
- Investments & AcquisitionsFirstline
& 1 more
- Acquired by
Associated legal entities of BSV Group
BSV Group operates through Bharat Serums And Vaccines Limited (amalgamated). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bharat Serums And Vaccines Limited CIN U24230MH1971PLC015134 | Amalgamated | 29 Apr 1971 | Mumbai, Maharashtra | ₹1,455 Cr | 1,731 | 12 | View details |
Products & Services of BSV Group
BSV Group offers a comprehensive portfolio of products and services, including Trinbelimab, Anti-Rho(D), Urinary Trypsin Inhibitor, and Recombinant FSH.
Recombinant Anti Rh(o)-D Immunoglobin for treating Rh incompatibility.
World's first biotech antibody for Rh incompatibility management.
Inhibitor used in critical care for inflammatory conditions.
Assists in fertility treatments for reproductive health issues.
Apps and channels of BSV Group
its YouTube channel Bharat Serums and Vaccines Limited (BSV) has 1.13K subscribers and 30 videos.
Videos from BSV Group
The most watched videos on BSV Group's YouTube channel, Bharat Serums and Vaccines Limited (BSV) (1.13K subscribers). Click a video to play it here.
Funding Insights of BSV Group
BSV Group has successfully raised a total of $64.91M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $46.76 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $64.91M
- Total Rounds 3
- Last Round Series C — $46.76M
- First Round $8.77M
(Nov 2008)
- Investors Count 2
All 3 funding rounds of BSV Group with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $46.76M | Series C | – | – | – |
| Mar 2010 | $9.39M | Private Equity Round | – | Orbimed | – |
| Nov 2008 | $8.77M | Private Equity Round | – | Kotak Mahindra Bank | – |
4 investors in total: 4 institutional.
Investors in BSV Group
BSV Group has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Kotak Mahindra Bank, Mankind Pharma and Orbimed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Private equity firm focused on multiple sectors | adventinternational.com | Sao Paulo, Brazil | ||
Commercial banking services are offered to corporate and retail customers. | 1985 | kotak.com | Mumbai, India | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | mankindpharma.com | Delhi, India |
Investor details for BSV Group
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Bharat Serums And Vaccines Limited (BSV Group)
Bharat Serums And Vaccines Limited is the primary company behind BSV Group. The board of Bharat Serums And Vaccines Limited currently have 10 directors; the longest-serving is Bharat Vinod Daftary, appointed in 1992. 33 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bharat Vinod Daftary DIN 00011518 | Director | 05 May 1992 | 34 yrs 5 mo | Bharat Serums And Vaccines Limited |
| Gautam Vinod Daftary DIN 00009326 | Director | 01 Oct 2011 | 15 yrs | Bharat Serums And Vaccines Limited |
| Shweta Jalan DIN 00291675 | Director | 07 Feb 2020 | 6 yrs 8 mo | Bharat Serums And Vaccines Limited |
| Abhijit Mangalmoy Mukherjee DIN 08610857 | Director | 07 Feb 2020 | 6 yrs 8 mo | Bharat Serums And Vaccines Limited |
| Sanjiv Hari Navangul DIN 02924640 | Managing Director | 07 Feb 2020 | 6 yrs 8 mo | Bharat Serums And Vaccines Limited |
| Jayesh Tulsidas Merchant DIN 00555052 | Director | 07 Feb 2020 | 6 yrs 8 mo | Bharat Serums And Vaccines Limited |
| Pankaj Patwari DIN 08206620 | Director | 07 Feb 2020 | 6 yrs 8 mo | Bharat Serums And Vaccines Limited |
| Bhaskar Vemban Iyer DIN 00480341 | Director | 07 Feb 2020 | 6 yrs 8 mo | Bharat Serums And Vaccines Limited |
| Chirag Ashokbhai Mehta DIN 02500707 | CFO | 15 Jul 2020 | 6 yrs 3 mo | Bharat Serums And Vaccines Limited |
| Anupama Diwakar Pai DIN 07881388 | Company Secretary | 14 Nov 2020 | 5 yrs 11 mo | Bharat Serums And Vaccines Limited |
People of BSV Group
1 people are tracked at BSV Group (1 in leadership).
| Name | Role | Group |
|---|---|---|
| CEO & MD | Leadership |
Complete people profiles for BSV Group
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of BSV Group
Figures of Bharat Serums And Vaccines Limited, the primary company behind BSV Group, for FY 2023. Revenue was ₹1,455 Cr (+15% year on year). Net profit was ₹51.64 Cr. EBITDA was ₹121 Cr (8% margin). Revenue has grown at a compounded annual rate of +17% over three years and +14% over five years.
- ₹1,455 CrRevenue · FY 2023 · +15% YoY
- ₹51.64 CrNet profit
- ₹121 CrEBITDA · 8% margin
- ₹9.01 CrPaid-up capital
- 1,731Employees (provident fund records)
- +17%Revenue CAGR, 3 years
- +14%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Bharat Serums And Vaccines Limited are on its company page.
Detailed financial statements for BSV Group
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BSV Group
BSV Group has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Firstline and Genomicks.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Medicines and diagnostic kits for fertility treatments are developed. | genomicks.com | Petaling Jaya, Malaysia | 2016 | Dec 2022 | •••• | |
Distributor of diversified drugs | firstline.com.my | Petaling Jaya, Malaysia | 2007 | Dec 2022 | •••• |
Complete acquisition details for BSV Group
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of BSV Group
7 dated milestones of BSV Group across 53 years, from founding to its latest funding, stage changes and deals.
- Founded BSV Group is founded.
- Funding First funding round of $8.8M.
- Exit Acquired by Advent International.
- Funding Latest funding round, Series C, of $46.8M.
- Acquisition Acquires Genomicks.
- Acquisition Acquires Firstline.
- Exit Acquired by Mankind Pharma.
Web traffic of BSV Group
The website of BSV Group (bsvgroup.com) receives about 7.2K visits a month and ranks #3,563,176 among all websites worldwide, #4,603 in Biotechnology and Pharmaceuticals.
- Monthly visits7.2K
▲ 35.3% vs previous month
- Unique visitors2.3K
per month
- Global rank#3,563,176
among all websites
- Category rank#4,603
Health · Biotechnology and Pharmaceuticals
- Bounce rate40%
- Pages per visit1.7
- Average visit37 sec
- DevicesDesktop 39% · Mobile 61%
Websites whose visitors overlap most with BSV Group. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| seruminstitute.com | 100% | 63.5K | #656,121 | View details | |
| bharatbiotech.com | 99% | 30.6K | #736,609 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bsv Group
Complete news archive for BSV Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BSV Group
BSV Group was founded in 1971 and raised its 1st funding round 37 years after it was founded.
BSV Group is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Sanjiv Navangul is the CEO of BSV Group, as recorded in our data.
BSV Group is a funded company, having raised a total of $64.91M across 3 funding rounds to date. The company's 1st funding round was a Private Equity Round of $8.77M, raised on Nov 2008.
The primary company behind BSV Group, Bharat Serums And Vaccines Limited, reported revenue of ₹1,455 Cr for FY 2023, up 15% year on year.
BSV Group, established in 1971 and currently in Acquired stage, focuses on providing healthcare solutions, diversified pharmaceuticals, and drugs. Provider of drug research development services for pharmaceutical sector. Adapting to market demands with innovation and client-focused strategies. It continues to evolve, meeting industry challenges with strategic approaches.
BSV Group offers Trinbelimab, Anti-Rho(D), Urinary Trypsin Inhibitor, and Recombinant FSH.
BSV Group has 4 investors. Key investors include Kotak Mahindra Bank, Mankind Pharma, Orbimed, and Advent International.
BSV Group operates through Bharat Serums And Vaccines Limited.
Yes. BSV Group was acquired by Advent International in November 2019.
The legal entities of BSV Group currently have 10 directors, including Shweta Jalan, Abhijit Mangalmoy Mukherjee, Chirag Ashokbhai Mehta and others.